Which hedge funds own VRDN? VIRIDIAN THERAPEUTICS INC, Q2 2026 13F holders
50 tracked hedge funds disclosed a position in VRDN (VIRIDIAN THERAPEUTICS INC) in their Q2 2026 13F filings, worth $906.0m in total. The largest holder by portfolio weight is Kynam Capital Management, LP at 6.6% of its book. 16 opened a new position this quarter: Caligan Partners LP, Ikarian Capital, LLC, Diadema Partners LP, Bayforest Capital Ltd. 21 exited: Propel Bio Management, LLC, Scientech Research LLC, MPM Bioimpact LLC.
- 50
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 16
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 21
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $86.0m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $68.4m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $906m
- Combined value Sum of the holders' reported positions in the security.
- 4.0%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Propel Bio Management, LLC | 2.6% | $4.1m |
| Scientech Research LLC | 1.1% | $1.3m |
| MPM Bioimpact LLC | 1.0% | $12.7m |
| Kopp Family Office, LLC | 0.7% | $1.1m |
| ADAR1 Capital Management, LLC | 0.4% | $6.0m |
| Birchview Capital, LP | 0.2% | $393k |
| EntryPoint Capital, LLC | 0.1% | $400k |
| ExodusPoint Capital Management, LP | 0.06% | $6.5m |
| CenterBook Partners LP | 0.05% | $887k |
| Fox Run Management, L.L.C. | 0.04% | $241k |
| Campbell & CO Investment Adviser LLC | 0.03% | $590k |
| Adage Capital Partners GP, L.L.C. | 0.03% | $19.0m |
| Cinctive Capital Management LP | 0.01% | $225k |
| J. Goldman & Co LP | 0.01% | $305k |
| Entropy Technologies, LP | 0.01% | $224k |
| Montanova Capital, LLC | 0.01% | $327k |
| Walleye Capital LLC | 0.01% | $1.1m |
| Qube Research & Technologies Ltd | 0.01% | $4.5m |
| Marshall Wace, LLP | 0.01% | $5.3m |
| Millennium Management LLC | 0.0% | $2.8m |
| Two Sigma Investments, LP | 0.0% | $687k |
Ownership over time
Who discovered VRDN first? Beta
| Commodore Capital LP high conviction | Q3 2022 | +5.2 pts |
| Fairmount Funds Management LLC high conviction | Q3 2021 | +2.0 pts |
| Soleus Capital Management, L.P. | Q2 2022 | +1.2 pts |
| Cormorant Asset Management, LP | Q1 2022 | +0.5 pts |
| Silverarc Capital Management, LLC | Q3 2021 | +0.4 pts |
| Logos Global Management LP | Q3 2022 | −0.2 pts |
| Venrock Adviser, LLC high conviction | Q3 2022 | −0.7 pts |
| Ally Bridge Group (NY) LLC high conviction | Q2 2021 | −2.0 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.